Decipher Labs Limited (BOM:524752)
India · Delayed Price · Currency is INR 6.20
+0.60 (10.71%)
At close: Sep 4, 2026
Decipher Labs Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 138.51 | 142.75 | 239.29 | 362.75 | 529.16 | 653.22 |
Revenue Growth | -28.11% | -40.34% | -34.03% | -31.45% | -18.99% | 17.57% |
Gross Profit Gross Profit Growth | 138.47 | 136.34 | 232.53 | 331.34 | 523.99 | 579.75 |
Operating Income Operating Income Growth | -24.48 | -36.85 | -6.55 | -3.59 | 28.29 | 131.97 |
Net Income Net Income Growth | -18.43 | -30.84 | -50.8 | -16.76 | -26.82 | 113.84 |
Earnings Per Share EPS Growth | -1.82 | -3.05 | -5.03 | -1.66 | -2.66 | 11.27 |
EPS Growth | - | - | - | - | - | 711.54% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Manufacturing and Trading of Pharmaceutical Drugs Manufacturing and Trading of Pharmaceutical Drugs Growth | -6.71 | 6.75 | 6.86 | 32.73 | 6.88 | 6.88 |
Consultancy Services Consultancy Services Growth | 37.65 | 133.79 | 219.27 | 326.05 | 448.85 | 646.34 |
Total Total Growth | 30.94 | 140.54 | 226.13 | 358.79 | 455.73 | 653.22 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 7.43 | 7.43 | 28.08 | 93.14 | 74.18 | 154.09 |
Total Debt Total Debt Growth | 5.03 | 5.03 | 2.45 | - | 9.49 | 103.22 |
Net Cash (Debt) Net Cash Growth | 2.4 | 2.4 | 25.64 | 93.14 | 64.68 | 50.87 |
Net Cash Growth | -90.65% | -90.65% | -72.47% | 43.99% | 27.16% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.24 | 0.24 | 2.54 | 9.22 | 6.40 | 5.04 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -20.83 | -98.18 | 48.54 | -15.65 | 82.65 |
Capital Expenditures CapEx Growth | - | -2.41 | -0.57 | -0.58 | -7.83 | -1.99 |
Free Cash Flow Free Cash Flow Growth | - | -23.24 | -98.75 | 47.96 | -23.48 | 80.66 |
Free Cash Flow Growth | - | - | - | - | - | 431.12% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 99.97% | 95.51% | 97.17% | 91.34% | 99.02% | 88.75% |
Operating Margin | -17.67% | -25.81% | -2.74% | -0.99% | 5.35% | 20.20% |
Pretax Margin | -17.67% | -25.81% | -26.69% | -3.34% | -7.86% | 18.92% |
Profit Margin | -13.31% | -21.61% | -21.23% | -4.62% | -5.07% | 17.43% |
FCF Margin | - | -16.28% | -41.27% | 13.22% | -4.44% | 12.35% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | - | 4.70 |
P/FCF Ratio | - | - | - | 3.11 | - | 6.63 |
PS Ratio | 0.45 | 0.35 | 0.44 | 0.41 | 0.27 | 0.82 |